“…Moreover, we previously reported that the carriers of the mutated allele did not display an increased platelet baseline reactivity or a different response to direct GP IIb/IIIa antagonists, among 80 patients undergoing percutaneous coronary intervention (PCI). 17 Finally, contrasting with the statement by Koza and Senocak, 1 we do not think that the treatment of a coronary lesion, either by percutaneous coronary intervention or surgery, can be equalized with a normal coronary artery. In fact, those patients already developed significant coronary atherosclerosis and therefore cannot be considered healthy patients.…”